La raideur, le blocage de la marche et la chute font partie des problèmes qui se manifestent lorsqu’une personne a … En savoir plus
Glutamate : l’autre substance chimique dans le cerveau
À l’Université McGill, le Dr Philippe Huot, neurologue et professeur adjoint, teste la capacité de nouveaux médicaments potentiels à réguler … En savoir plus
Aid médicale à mourir (AMM) – partagez votre opinion
Le gouvernement du Canada a annoncé une consultation publique sur l’aide médicale à mourir (AMM) qui prendra fin le 27 … En savoir plus
’Tis the Season for Growth and Reflection
This was a very exciting year of change, growth and carving new paths. Since the union of six Parkinson’s organizations … En savoir plus
To Paint — To Dream
Susan Bucovetsky was diagnosed with Parkinson’s over 12 years ago. Susan has been painting for numerous years in Montreal, Quebec. … En savoir plus
Seeking a synaptic solution to Parkinson’s disease
Dr. Hideto Takahashi, a researcher at the Montreal Clinical Research Institute, has pointed to a protein called neurexin as a … En savoir plus
Weighing the therapeutic potential of omega-3 and exercise
Olivier Kerdiles, a doctoral student at Université Laval, is exploring the possibility that diet and exercise could prevent the onset … En savoir plus
Ambassadors lay the foundation to advocate to the new government
This Fall, Parkinson Canada launched a Plan for Parkinson’s that includes improved access to care for people with Parkinson’s and … En savoir plus
Working to improve good communication between people with Parkinson’s, their care partners and health professionals
Healthcare professionals committed to clear and compassionate communication can make a meaningful difference to their patients. When people with Parkinson’s … En savoir plus
Putting saliva to good use
If researchers could find a non-invasive, physiological tool to diagnose Parkinson’s disease, it might be easier to start treatment earlier. … En savoir plus